Emergent BioSolutions
EBS
#6766
Rank
โ‚น57.03 B
Marketcap
โ‚น1,069
Share price
-1.24%
Change (1 day)
37.97%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): โ‚น14.36 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are โ‚น0.75 Billion. In 2024 the company made an earning of -โ‚น6.46 Billion, an increase over its 2023 earnings that were of -โ‚น57.8 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น14.36 B-322.45%
2024 -โ‚น6.46 Billion-88.82%
2023 -โ‚น57.8 Billion242.73%
2022 -โ‚น16.87 Billion-153.8%
2021 โ‚น31.34 B-20.43%
2020 โ‚น39.39 B278.02%
2019 โ‚น10.42 B27.11%
2018 โ‚น8.19 B-27.12%
2017 โ‚น11.24 B17.21%
2016 โ‚น9.59 B0.45%
2015 โ‚น9.55 B73.51%
2014 โ‚น5.50 B41.36%
2013 โ‚น3.89 B35.2%
2012 โ‚น2.88 B0.4%
2011 โ‚น2.87 B-56.46%
2010 โ‚น6.59 B76.73%
2009 โ‚น3.72 B32.94%
2008 โ‚น2.80 B-5.62%
2007 โ‚น2.97 B
2005 โ‚น4.30 B269.89%
2004 โ‚น1.16 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
โ‚น2.074 T 13,868.54%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น8.11 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น837.53 B 5,539.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-โ‚น23.02 Billion-255.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.064 T 7,069.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น159.19 B 971.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
-โ‚น1.12 Billion-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA